Wow I guess shareholders got a lucky break when the takeover by...

Wow I guess shareholders got a lucky break when the takeover by Thorate was knocked back! I was thinking this thing might get to $4 in twelve months but this development is huge. "We have been gratified by the support received from all of the prestigious cardiac centers that have participated in our bridge-to-transplant trial and we believe that this study, the largest head-to-head VAD clinical trial to date, will be compelling for cardiologists, surgeons and end-stage heart failure patients."